证券代码：688329 证券简称：艾隆科技 公告编号：2025-032 苏州艾隆科技股份有限公司 2025 年员工持股计划第一次持有人会议决议公告 （二）审议通过《关于选举公司 2025 年员工持股计划管理委员会委员的议 案》 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、持有人会议召开情况 苏州艾隆科技股份有限公司（以下简称"公司"）2025 年员工持股计划第 一次持有人会议（以下简称"持有人会议"）于 2025 年 6 月 23 日以现场结合通 讯的方式召开，本次会议由徐立先生召集和主持。本次会议应出席持有人 29 人， 实际出席会议持有人 29 人，代表公司 2025 年员工持股计划有表决权的份额为 17,632,800 份，占公司 2025 年员工持股计划总份额的 100%。 本次会议的召集、召开和表决程序符合有关法律、行政法规、部门规章、规 范性文件及《苏州艾隆科技股份有限公司 2025 年员工持股计划（草案）》（以 下简称"《2025 年员工持股计划》"）和《苏州艾隆科技股份有限公司 2025 年 员工持 ...

Group 1 - The meeting of the fifth supervisory board of Suzhou Ailong Technology Co., Ltd. was held on June 6, 2025, with all three supervisors present, complying with legal and regulatory requirements [1] - The supervisory board approved the proposal regarding the acquisition of assets and related transactions by its controlling subsidiary, Ailong Special, which aligns with the company's overall development strategy and supports sustainable growth [1] - The supervisory board concluded that the pricing of the related transaction is fair and does not harm the interests of the company and all shareholders, especially minority shareholders [1]

证券代码：688329 证券简称：艾隆科技 公告编号：2025-030 苏州艾隆科技股份有限公司 关于控股子公司购买资产暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 苏州艾隆科技股份有限公司（以下简称"公司"）控股子公司艾隆科技医 疗专项工程技术（滁州）有限公司（以下简称"艾隆专项"）拟向筑医台（滁州） 产业科技有限公司（以下简称"滁州筑医台"）购买筑医台（滁州）美好医院集成 创新基地（以下简称"创新基地"）标准化厂房 19 号 3,752.09 平方米（以下简称"交 易标的"），交易价格为人民币 16,133,987 元（含增值税）（以下简称"本次交易"）。 本次交易构成关联交易，但不构成重大资产重组。 本次交易的实施不存在重大法律障碍。 本次交易已经公司第五届董事会第二次独立董事专门会议、第五届董事 会第七次会议以及第五届监事会第六次会议审议通过，关联董事已回避表决，本 次交易无需提交股东大会审议。 一、关联交易概述 公司控股子公司艾隆专项基于业务发展需要，拟与滁州筑医台签署《筑医台 ...

证券代码：688329 证券简称：艾隆科技 公告编号：2025-031 苏州艾隆科技股份有限公司（以下简称"公司"）第五届监事会第六次会议 于 2025 年 6 月 6 日在公司会议室以现场方式召开，会议通知已于 2025 年 6 月 3 日通过邮件的方式送达各位监事。本次会议由监事会主席张春兰主持，会议 应出席监事 3 名，实际出席 3 名。会议召开符合法律法规、《公司法》及《公 司章程》的规定。 苏州艾隆科技股份有限公司 第五届监事会第六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 表决结果：同意 3 票；反对 0 票；弃权 0 票，回避 0 票。 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的 《苏州艾隆科技股份有限公司关于控股子公司购买资产暨关联交易的公告》 （公告编号：2025-030）。 特此公告。 苏州艾隆科技股份有限公司监事会 2025 年 6 月 7 日 二、监事会会议审议情况 （一）审议通过《关于控股子公司购买资产暨关联交易的议案 ...

Group 1 - The company has approved a share repurchase plan to buy back its A-shares using its own funds, with a maximum repurchase price of RMB 23.20 per share and a total repurchase amount between RMB 1.5 million and RMB 3 million [1] - The repurchase period is set for 12 months from the date of the board's approval [1] - As of May 31, 2025, the company has not yet implemented any share repurchases [2] Group 2 - The company will adhere to relevant regulations and make repurchase decisions based on market conditions during the repurchase period [3] - The company commits to timely information disclosure regarding the progress of the share repurchase [3]

证券代码：688329 证券简称：艾隆科技 公告编号：2025-029 苏州艾隆科技股份有限公司 关于以集中竞价交易方式回购公司股份 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/4/29 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 年 月 2025 4 4 | 25 | 日~2026 | 年 | 月 | 日 24 | | 预计回购金额 | 150万元~300万元 | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 □用于转换公司可转债 | | | | | | | | □为维护公司价值及股东权益 | | | | | | | 累计已回购股数 | 0万股 | | | | | | | 累计已回购股数占总股本比例 | 0% | | | | | | | 累计已回购金额 | 0万元 | | | | | | | 实际回购价格区间 | 0元/股~0元/股 | ...

Core Viewpoint - Ailong Technology (688329.SH) reported a decline in revenue and net profit for the fiscal year 2024, with a significant net loss, while cash flow from operating activities showed a positive trend [1][3]. Financial Performance Summary - For the fiscal year 2024, the company achieved operating revenue of 325.29 million yuan, a decrease of 10.52% compared to the previous year [1][3]. - The net profit attributable to shareholders was -21.70 million yuan, a decline of 173.52% from the previous year's profit of 29.52 million yuan [1][3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -38.09 million yuan, compared to a profit of 17.97 million yuan in the previous year [1][3]. - The net cash flow from operating activities was 99.47 million yuan, an increase of 10.75% year-on-year [1][3]. Q1 2025 Performance Summary - In the first quarter of 2025, the company reported operating revenue of 56.07 million yuan, a slight increase of 0.44% year-on-year [1][4]. - The net profit attributable to shareholders was -1.42 million yuan, compared to -1.40 million yuan in the same period last year [1][4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -1.45 million yuan, slightly worse than -1.40 million yuan in the previous year [1][4]. - The net cash flow from operating activities was -1.91 million yuan, a decline from -0.46 million yuan in the same period last year [1][4].

Group 1 - The company will hold an annual performance briefing for 2024 and the first quarter of 2025 on June 3, 2025, from 13:00 to 14:00 [1][2] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [1][2] - Investors can submit questions for the briefing from May 27, 2025, to June 2, 2025, before 16:00 [1][2] Group 2 - The briefing aims to provide a comprehensive understanding of the company's operational results and financial status for 2024 and the first quarter of 2025 [1][2] - Key participants in the briefing will include the Chairman and General Manager, Xu Li, the Financial Director, Li Wanfeng, and the Independent Director, Zhu Leilei [2] - After the briefing, investors can access the main content and details of the event through the Shanghai Stock Exchange Roadshow Center [2]

证券代码：688329 证券简称：艾隆科技 公告编号：2025-028 苏州艾隆科技股份有限公司 关于召开 2024 年年度暨 2025 年第一季度业绩说明会 的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 5 月 27 日（星期二）至 6 月 2 日（星期一）16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过苏州艾隆科技股份有限 公司（以下简称"公司"）邮箱 8103@iron-tech.cn 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 一、说明会类型 公司已于 2025 年 4 月 29 日披露公司《2024 年年度报告》和《2025 年第一 季度报告》，为便于广大投资者更全面深入地了解公司 2024 年年度和 2025 年第 一季度经营成果、财务状况，公司计划于 2025 年 6 月 3 日（星期二）下午 13:00-14:00 举行 2 ...

Group 1 - The core business of Suzhou Ailong Technology Co., Ltd. focuses on intelligent management of medical supplies, providing comprehensive solutions for medical institutions [1] - The company's main products include automated pharmacies, automated wards, and automated logistics [1] - As of the first quarter of 2025, the company reported revenue of 56.068 million yuan, a year-on-year increase of 0.44%, and a net profit of -14.166 million yuan, a year-on-year decrease of 1.42%, with a gross profit margin of 42.75% [1] Group 2 - Ailong Technology's latest closing price was 17.12 yuan, up 1.97%, with a market-to-book ratio of 1.79, marking a new low in 44 days, and a total market capitalization of 1.322 billion yuan [1] - As of the first quarter of 2025, there are four institutional holders of Ailong Technology, including three other entities and one fund, holding a total of 3.3392 million shares valued at 5.1 million yuan [1] - The company's PE (TTM) is -60.35, while the industry average PE is 62.88, indicating a significant divergence from industry performance [2]